The independent source for health policy research, polling, and news.
5,881-5,900 of 112,929 results
The pharma company behind runaway success weight-loss drug Wegovy is looking into future obesity drug technology. Separately, a long-term study shows that exercise can help people keep from gaining weight after they've been taking a weight-loss drug.
Patients are voicing concerns about changes to health service quality and offerings from providers that Amazon bought, such as Iora Health clinics' parent company One Medical. Meanwhile, construction of a new Kaiser Permanente hospital in San Jose is set for 2025.
Editorial writers discuss a deadly pesticide, hospital boarding, self-defense laws, and more.
About the same number of abortions are happening each month now as before the reversal of Roe v. Wade, a new report by the Society of Family Planning says. The report also shows abortions via telehealth have been rising, with pills mailed to patients after online consultations.
Also in the news: A study examines long covid "brain fog" and the potential impact on IQ; scientists look at the medical challenges children hospitalized with covid continue to face; an uptick in post-covid prescriptions for depression and anxiety; covid's impact on health care quality; and more.
The latest physical evaluating President Joe Biden's health reportedly drew on 20 doctors' expertise, but did not involve a cognitive exam of the 81 year-old politician. Also in the news, protections for disabled travelers; a challenge to the bump stock device weapons ban; and more.
A bill introduced by Sen. Tammy Duckworth, a Democrat from Illinois, was blocked Wednesday by Sen. Cindy Hyde-Smith, a Republican from Mississippi. The legislation would have provided federal protections for in vitro fertilization treatments. The Biden campaign linked the move to former President Donald Trump, arguing that he would have urged Republicans to pass it if he truly supported IVF access.
Congressional leaders have reached agreement on a stopgap bill that will extend two-tier federal funding deadlines to March 8 and March 22, in an effort to secure enough time to finalize the spending deal that's been secured "in principle."
Today's early morning highlights from the major news organizations.
Read recent pharmaceutical developments in KFF Health News' Prescription Drug Watch roundup.
Consuming marijuana via smoking, vaping, or edibles was linked to higher risks even if the person had no previous conditions and didn't use tobacco, a new study found. Meanwhile, the FDA may roll out a new "healthy" logo to promote food products that really are healthy.
Goldman Sachs analysts suggested in a report that because poor health hurts the economy, better health outcomes thanks to drugs like Wegovy and Ozempic could thus boost economic output. Separately, a new study shows Americans are doubtful the drugs can fix the obesity epidemic.
Read recent commentaries about pharmaceutical issues.
Editorial writers tackle cannabis, measles, heart disease, and more.
A federal appeals court ruled that Indiana can indeed block young transgender people from accessing hormone and puberty blocker treatments, which form part of gender care, undoing a lower court decision that had blocked the law. Also in the news: pain and suffering jury award caps.
California confiscated a 62,000 pounds of fentanyl at its ports of entry in 2023 -- “enough to potentially kill the global population nearly twice over,” Gov. Gavin Newsom’s office said Tuesday -- and up from 28,000 pounds seized the year before.
Dr. Joseph Ladapo "politicizes public health and peddles risky freedom of choice rhetoric" said Rep. Debbie Wasserman Schultz, a Florida Democrat, criticizing the handling of the measles outbreak by her state's surgeon general. Meanwhile, another case was reported at a Florida elementary school.
The Wall Street Journal reports that the Justice Department has opened an antitrust probe into health care giant United Health. Investigators have been questioning competitors about the the company’s doctor group acquisitions.
An inquiry by the FTC into the role of pharmacy benefit managers on prescription drug costs has been stymied so far as the companies involved have not produced requested documents, Stat reports. In related news, advocates for PBM reform continue to push for measures that look to be dropped from the government spending package.
“I warned that red states would come for IVF — and now they have,” said Sen. Tammy Duckworth, a Democrat. The group is pushing Republican colleagues to not block a bill that would preserve access to IVF technology. Axios also reports that President Joe Biden's next moves on IVF may be limited.
© 2026 KFF